Our Happy Clients
The novel combination of Elbasvir and Grazopavir is now available as a Zepatier tablet. This combo pill represents a significant advance in the treatment of chronic hepatitis C virus (HCV) infection. Elbasvir and Grazopavir are both direct-acting antiviral drugs that inhibit the replication of the HCV virus by inhibiting the function of specific proteins. There are 50 mg of Elbasvir and 100 mg of Grazopavir in each pill.
It has been determined that this combination of Elbasvir and Grazopavir is highly successful at suppressing the HCV virus in the majority of patients. Within 12 weeks of therapy, clinical trials have indicated that the combination can lower the level of HCV in the body by more than 95%.
|
Name |
Zepatier tablet |
|
Salt |
Elbasvir & grazopavir 50mg / 100mg |
|
Manufactured By |
Merck Ltd |
|
Packaging |
Tablet |
|
Use |
Anti HIV drug |
Product Delivery is a customer-centric approach to defining.
Product Delivery is a customer-centric approach to defining.
Product Delivery is a customer-centric approach to defining.